Skip to main content
. 2016 Oct 12;7(46):76036–76046. doi: 10.18632/oncotarget.12582

Figure 6. SOX17 suppressed tumor growth in vivo.

Figure 6

Tumors from xenograft-transplanted nude mice 32 days after subcutaneous injection of SOX17-overexpressing, silenced or control HEC-1B cells A. Weights of xenografts 32 days after cell injection (*P<0.05) B. In vivo tumor growth curves for HEC-1B cells C. Paraffin-embedded sections obtained from xenografts D. IHC staining shows increased MAML3, β-catenin, CyclinD1, c-Myc and Ki67 expression in the SOX17 knockdown group compared to controls.